Ieq Capital LLC reduced its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 1.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,415 shares of the medical equipment provider’s stock after selling 357 shares during the quarter. Ieq Capital LLC’s holdings in Align Technology were worth $8,550,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Gryphon Financial Partners LLC raised its holdings in Align Technology by 31.0% during the 4th quarter. Gryphon Financial Partners LLC now owns 1,396 shares of the medical equipment provider’s stock valued at $383,000 after buying an additional 330 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Align Technology by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 213,667 shares of the medical equipment provider’s stock valued at $58,548,000 after acquiring an additional 7,266 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of Align Technology by 34.0% in the 4th quarter. Janney Montgomery Scott LLC now owns 12,546 shares of the medical equipment provider’s stock worth $3,438,000 after acquiring an additional 3,185 shares during the last quarter. Coldstream Capital Management Inc. boosted its stake in shares of Align Technology by 19.2% during the 4th quarter. Coldstream Capital Management Inc. now owns 1,941 shares of the medical equipment provider’s stock worth $532,000 after purchasing an additional 313 shares during the period. Finally, D.A. Davidson & CO. grew its holdings in Align Technology by 4.5% during the 4th quarter. D.A. Davidson & CO. now owns 4,644 shares of the medical equipment provider’s stock valued at $1,272,000 after purchasing an additional 200 shares during the last quarter. 88.43% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, Director C Raymond Larkin, Jr. bought 6,500 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were acquired at an average price of $235.33 per share, with a total value of $1,529,645.00. Following the transaction, the director now owns 28,247 shares of the company’s stock, valued at $6,647,366.51. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.62% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Read Our Latest Report on ALGN
Align Technology Price Performance
ALGN stock opened at $257.17 on Friday. Align Technology, Inc. has a 1-year low of $176.34 and a 1-year high of $335.40. The business has a 50-day moving average price of $232.30 and a 200 day moving average price of $265.24. The company has a market capitalization of $19.36 billion, a P/E ratio of 42.37, a PEG ratio of 5.13 and a beta of 1.64.
Align Technology (NASDAQ:ALGN – Get Free Report) last posted its quarterly earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 EPS for the quarter, beating the consensus estimate of $2.32 by $0.09. Align Technology had a net margin of 11.34% and a return on equity of 14.07%. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the previous year, the business posted $1.73 EPS. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. On average, analysts anticipate that Align Technology, Inc. will post 7.61 earnings per share for the current fiscal year.
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Articles
- Five stocks we like better than Align Technology
- Stock Sentiment Analysis: How it Works
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- NYSE Stocks Give Investors a Variety of Quality Options
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Find and Profitably Trade Stocks at 52-Week Lows
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.